SCHEMBL2935148

SCHEMBL2935148

CC(C)Cc1ccc(N2CC(=O)NS2(=O)=O)c(O)c1.CCCCCCc1ccc(N2CC(=O)NS2(=O)=O)c(O)c1.CCc1ccc(N2CC(=O)NS2(=O)=O)c(O)c1

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 6/20 0.43
PRKCG P05129 6/20 0.39
PRKCB P05771 6/20 0.39
PRKCH P24723 6/20 0.39
PRKCE Q02156 6/20 0.39
PRKCQ Q04759 6/20 0.39
PRKCD Q05655 6/20 0.39
PRKCA P17252 5/20 0.39
PPARA Q07869 1/20 0.38
PRKD3 O94806 3/20 0.37
PRKCI P41743 3/20 0.37
PRKCZ Q05513 3/20 0.37
PRKD1 Q15139 3/20 0.37
KAT8 Q9H7Z6 2/20 0.35
PTPN2 P17706 2/20 0.35
S1PR4 O95977 1/20 0.35
S1PR1 P21453 1/20 0.35
S1PR3 Q99500 1/20 0.35
S1PR5 Q9H228 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3926402 0.90 PTPN1 (0.50) PTPN1PRKCGPRKCBPRKCHPRKCE
SCHEMBL3220267 0.88 PTPN1 (0.48) PTPN1PRKCGPRKCBPRKCHPRKCE
SCHEMBL3923934 0.87 PTPN1 (0.53) PTPN1PTPN2
SCHEMBL3919036 0.84 PTPN1 (0.56) PTPN1PTPN2
SCHEMBL2936209 0.82 PTPN1 (0.50) PTPN1PRKCGPRKCBPRKCHPRKCE
SCHEMBL3213618 0.80 PTPN1 (0.47) PTPN1PTPN2
SCHEMBL3219608 0.78 PTPN1 (0.54) PTPN1PTPN2
SCHEMBL630202 0.78 PTPN1 (0.63) PTPN1PPARAKAT8PTPN2S1PR4
SCHEMBL3920002 0.78 PTPN1 (0.52) PTPN1PTPN2
SCHEMBL2935153 0.77 PPARA (0.33) PRKCGPRKCBPRKCHPRKCEPRKCQ

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2227245-A2 COMBINATION OF PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND HUMAN GROWTH HORMONE FOR THE TREATMENT OF MUSCLE ATROPHY AND RELATED DISORDERS Novartis AG (CH) 2010-09-15 EP disclosed
WO-2009068689-A2 COMBINATION OF PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND HUMAN GROWTH HORMONE FOR THE TREATMENT OF MUSCLE ATROPHY AND RELATED DISORDERS NOVARTIS AG (CH) 2009-06-04 WO disclosed